Ajay Kirtane
Latest contributions
Hypertension interventions in specific scenarios
22 May 2025 – From EuroPCR 2025
Explore interventions for hypertension in specific patient populations, including renal artery stenosis treatment and the role of renal denervation. Discuss multidisciplinary approaches and evidence supporting renal denervation in advanced kidney disease, heart failure, and young patients.
New frontier in renal denervation: data, devices and developments
22 May 2025 – From EuroPCR 2025
Advance your understanding of renal denervation with the latest data, innovative devices, and emerging developments. This session reviews the 12-month results of the REDUCED 1 trial evaluating the TIVUS system, explores safety and efficacy of novel renal stimulation techniques, and presents outcomes from registries including patients...
DCB after REC-CAGEFREE 1 - Vulnerable plaque PCI after PREVENT
21 May 2025 – From EuroPCR 2025
Reflect on the impact of recent trials REC-CAGEFREE 1 and PREVENT on the use of drug-coated balloons (DCB) and preventive PCI for vulnerable plaque. This session includes case discussions highlighting DCB applications and insights from cutting-edge clinical studies.
Evolving bifurcation treatment practices: drug-coated balloons, angio-based FFR, and side branch optimisation
20 May 2025 – From EuroPCR 2025
Explore how bifurcation treatment is evolving with the integration of drug-coated balloons, angio-based FFR, and advanced side branch optimisation. This EuroPCR 2025 session highlights why DCB is gaining traction for bifurcation lesions and introduces the upcoming EBC-DCB trial comparing a stepwise DCB strategy to provisional DES...
Complex PCI in calcific coronary artery disease - LIVE Case
20 May 2025 – From EuroPCR 2025
A 76-year-old male patient presented with a significant history of coronary artery disease: CABG with LIMA/LAD and RIMA/OM (1996), RCA PCI with BVS (2016), OM PCI (2017), RIMA occlusion and OM retenosis treated with DCB (2022) with preserved LV. He was admitted for pre-operative evaluation prior...
New solutions for old problems
19 May 2025 – From EuroPCR 2025
Discover new solutions addressing persistent cardiovascular challenges, including novel diagnostic systems, vascular closure devices, specialized transcatheter closure technologies, and innovative stent-graft systems.
uRDN now - The third pillar for hypertension treatment
16 May 2024 – From EuroPCR 2024
Tune into this session to stay updated on the cutting-edge clinical evidence, guidelines, and technology surrounding renal denervation. Explore firsthand clinical experiences with ultrasound renal denervation and gain practical insights into patient selection through individual, real-world case discussions. Engage in discussions on integrating ultrasound renal denervation...
CathWorks FFRangio - Enhancing patient care
16 May 2024 – From EuroPCR 2024
Explore this EuroPCR 2024 session to gain an in-depth understanding of how FFRangio utilizes routine angiograms to provide valuable insights, delve into the integration of FFRangio-guided decisions for optimizing patient care, and examine the practical application of FFRangio in routine clinical practice, encompassing its benefits and challenges.
Multivessel disease PCI guided by physiology and IVUS - LIVE case
16 May 2024 – From EuroPCR 2024
A 78-year-old woman with hypertension, dyslipidemia, and obesity, presented with angina CCS2 and preserved LV function. The coronary angiogram showed stenosis in the RCA (proximal and mid), CX, and calcified proximal and mid LAD involving D1 and D2.
The operators performed PCI on the RCA (1 stent)...
Tools and technologies guiding decision making in bifurcation PCI
15 May 2024 – From EuroPCR 2024
In this session, discover that provisional stenting in routine non-LM bifurcation using Resolute Onyx DES yields good mid-term outcomes without side branch intervention, provided the stent is sized to the distal reference and the side branch remains patent after a systematic POT. Learn how bifurcation stenting...
Renal denervation step by step: how to perform a safe and effective procedure
14 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of renal denervation, covering the essential aspects of patient selection, preprocedural assessment and imaging, the technical steps for performing safe and effective radiofrequency and ultrasound-based renal denervation, and the importance of post-procedural follow-up. The discussions aim to equip the audience...
Innovations in renal denervation: deja vu or reality?
13 May 2024 – From EuroPCR 2024
How have REVIVED (percutaneous revascularization for ischemic left ventricular dysfunction) results changed my practice?
17 May 2023 – From EuroPCR 2023
Mirvat Alasnag and Ajay Kirtane reflect on the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunction) randomised trial 9 months after its release. They discuss how the unexpected results had an effect on their practice, and how results compare to those of the STICH trial.
Integrating FFRangio into your daily practice - Empowering wire-free insights
18 May 2023 – From EuroPCR 2023
In this session, dive into the world of FFRangio, from concept to clinical reality, and then analyze different cases in real practice to see how useful the physiology is, to try to understand why it is still so little used, and to learn how FFRangio could...
Breaking the calcium ceiling in bifurcation stenoses with contemporary PCI
18 May 2023 – From EuroPCR 2023
Watch the case of a 73-year-old man, active smoker, with HTN, dyslipidaemia and a history of severe polyvascular disease, who presented with CCS III angina in the last two months, and find out in this session how he was treated LIVE.
REVIVED: will this trial change my practice?
17 May 2023 – From EuroPCR 2023
Within this collection of slides, acquire insights into the efficient management of patients with ischaemic heart disease and the identification of those who may benefit from revascularisation. Delve into a thorough review of the REVIVED trial, encompassing its methods, results, and conclusions.
Ultra-low contrast PCI - An indispensable toolset in complex coronary interventions and higher-risk patients
17 May 2023 – From EuroPCR 2023
Discover the indispensable toolset of ultra-low contrast (ULC) percutaneous coronary intervention (PCI) in complex coronary interventions and higher-risk patients in this session. Gain a comprehensive understanding of how ULC PCI can enhance the safety and quality of revascularization in complex procedures and learn practical aspects from...
Orbital atherectomy, a versatile tool in managing complex scenarios of vessel calcification
17 May 2023 – From EuroPCR 2023
The aim of this session is to address the question of how to optimise outcomes for high-risk patients by analyzing two real-life cases for discussion: a distal calcified left main trifurcation and a high-risk PCI with orbital atherectomy.
Modern management of PCI in complex lesions
18 May 2023 – From EuroPCR 2023
Watch Mirvat Alasnag, Ajay Kirtane and Flavio Ribichini as they talk modern PCI right in the middle of EuroPCR 2023.
They start by distinguishing between a complex patient and a complex lesion, and go on to define a complex PCI. Then they highlight the role of intracoronary...
Going down the road of coronary artery disease treatment: sirolimus-coated balloon and DES + DCB stent platform
16 May 2023 – From EuroPCR 2023
What better way to talk about sirolimus-coated balloons than with real-life clinical cases? In this session, study the case of a 78-year-old man with crescendo angina and inferior wall ischaemia, or a 48-year-old woman with crescendo angina, type 2 DM and anterior wall hypokinesia with mild...
Results from the DCR4Contrast (Dynamic Coronary Roadmap for Contrast reduction) Trial
16 May 2023 – From EuroPCR 2023
Javier Escaned joins Ajay Kirtane to discuss the DCR4C Trial he conducted, and more specifically to present the main results.
The framework of the study was the contrast reduction during PCI, which is closely related to what is now known as ultra-low contrast PCI, and which mainly concerns particularly...
Incorporating coronary orbital atherectomy to my practice
18 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to examine the improvement of technology in the treatment of highly calcified coronary lesions: get a practical perspective on how to integrate and perform orbital atherectomy in your clinical practice, become aware of its differential aspects compared to other plaque preparation...
Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.
Is DK Crush the optimal two-stent bifurcation strategy for left main PCI?
17 May 2022 – From EuroPCR 2022
In this EuroPCR 2022 session, follow the discussion around the recorded case of a 67-year-old non-smoking male patient who presented with chest pain on exertion typical of angina for one month, and learn how to optimally treat a severely calcified long lesion, understand how imaging can...
EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in hypertension management! Blood pressure and MACE reductions after renal denervation: 3-year GSR results, patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio, and SPYRAL-HTN ON MED 3 year data.
Latest insights: when to choose orbital atherectomy
20 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Van Mieghem, Surendra Avula and Ajay Kirtane in order to understand the challenges of treating severe calcium, to know about the OAS overview with dual-action MOA technology and the clinical evidence supporting its use, and to be introduced to treatment technique.
A review of the RADIANCE-HTN global clinical trial programme: a focus on the TRIO cohort
18 May 2021 – From EuroPCR 2021
Watch this session presented by Ajay Kirtane, Melvin David Lobo and Felix Mahfoud in order to review a history of the field and the recent clinical advancements in renal denervation with the Paradise Ultrasound RDN system, to further examine the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered...
Crossover results from the RADIANCE-HTN SOLO trial
26 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to learn about latest results from RADIANCE-HTN SOLO cohort and to review blood pressure results following crossover to ultrasound RDN in patients originally randomised to the sham arm in RADIANCE-HTN SOLO.
Videos included on this page: the Hot Line presentation, an...
PCR e-Course 2020 Late-Breaking Trials – part 1
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- Crossover results from the RADIANCE-HTN SOLO trial
- DynamX Bioadaptor, a novel « uncaging » platform
- Two-stent vs. provisional for bifurcation PCI: the DEFINITION II trial
Ultrasound renal denervation: RADIANCE-HTN SOLO results
What is the latest evidence on the efficacy and safety of ultrasound renal denervation in treating hypertension? Reintroducing antihypertensive medication to patients previously treated with renal denervation is under discussion as Felix Mahfoud, Michel Azizi and Ajay Kirtane consider the 6-month results from the RADIANCE-HTN SOLO...
